线上和线下联合的癌症多学科综合治疗协作组诊疗模式探讨

doi:10.3760/cma.j.cn371439-20200612-00074

国际肿瘤学杂志 ›› 2020, Vol. 47 ›› Issue (9): 542-545.doi: 10.3760/cma.j.cn371439-20200612-00074

线上和线下联合的癌症多学科综合治疗协作组诊疗模式探讨

杨光惠^1,², 王茜^1,², 李哲奇³, 刘成新^1,², 孙洪福^1,², 李喆³, 张海波², 李洪升²(), 李宝生²()

¹山东大学齐鲁医学部临床医学院,济南 250012
²山东省肿瘤防治研究院(山东省肿瘤医院)放疗科,山东第一医科大学(山东省医学科学院),济南 250117
³济南大学山东省医学科学院医学与生命科学学院 250022

收稿日期:2020-06-12 修回日期:2020-07-25 出版日期:2020-09-08 发布日期:2020-10-27
通讯作者: 李洪升,李宝生 E-mail:xbloom@163.com;baoshli1963@163.com

Discussion on online and offline combined multidisciplinary team diagnosis-treatment mode for cancers

Yang Guanghui^1,², Wang Qian^1,², Li Zheqi³, Liu Chengxin^1,², Sun Hongfu^1,², Li Zhe³, Zhang Haibo², Li Hongsheng²(), Li Baosheng²()

¹School of Medicine, Cheeloo College of Medicine of Shandong University, Jinan 250012, China
²Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
³School of Medicine and Life Science, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250022, China

Received:2020-06-12 Revised:2020-07-25 Online:2020-09-08 Published:2020-10-27
Contact: Li Hongsheng,Li Baosheng E-mail:xbloom@163.com;baoshli1963@163.com

摘要/Abstract

摘要：

目的通过对比线上和线下两种多学科综合治疗协作组(MDT)诊疗模式制定的综合诊疗方案,探讨采用线上和线下联合的癌症MDT诊疗模式的可行性。方法以2020年3月17日至2020年5月17日山东省肿瘤医院采用线上和线下MDT诊疗模式的168例食管癌患者为研究对象,评价线上和线下MDT诊疗模式制定的综合诊疗方案的一致性,并分析综合诊疗方案不同患者的临床特征,如年龄、Karnofsky功能状态(KPS)评分、是否合并基础疾病、入院前是否接受抗肿瘤治疗及肿瘤位置,从而探讨如何在保证质量的基础上,提高MDT诊疗模式效率。结果线上和线下MDT诊疗模式制定的综合诊疗方案一致的比例为86.3%(145/168)。综合诊疗方案不一致的病例特征表现为高龄(>69岁)(χ²=4.250,P=0.039)、KPS评分≥80分(χ²=15.520,P<0.001)及合并基础疾病(χ²=7.135,P=0.008)。进一步分析发现,综合诊疗方案不一致的病例还表现为辅助检查不完善及影像学疑难的特征。结论线上和线下联合的癌症MDT诊疗模式是可行的。对于高龄(>69岁)、KPS评分≥80分、合并基础疾病、辅助检查不完善或影像学疑难的病例,应采用或补充线下MDT诊疗模式讨论。

关键词: 肿瘤, 多学科综合治疗协作组, 诊断, 治疗

Abstract:

Objective To discuss the feasibility of using online and offline combined multidisciplinary team (MDT) diagnosis-treatment mode in cancers diagnosis and treatment by comparing the comprehensive diagnosis and treatment plans formulated by online and offline MDT diagnosis-treatment mode. Methods A total of 168 esophageal cancer patients collected from March 17, 2020 to May 17, 2020 were took as the research objects in Shandong Cancer Hospital and Institute, through whom the consistency of the comprehensive diagnosis and treatment plans formulated by online and offline MDT diagnosis-treatment mode was evaluated. The clinical characteristics of patients with changed comprehensive diagnosis and treatment plans, such as age, Karnofsky performance status (KPS) score, whether combined with basic diseases, whether received anti-tumor treatment before and tumor location were analyzed, so as to explore the mechanism to improve the efficiency on the basis of quality assurance. Results The results showed that 86.3% (145/168) of the comprehensive diagnosis and treatment plans obtained by offline MDT diagnosis-treatment mode were consistent with online diagnosis-treatment MDT mode. Cases with inconsistent comprehensive diagnosis and treatment plans were characterized by elderly (> 69 years) (χ²=4.250, P=0.039), KPS score≥80 (χ²=15.520, P<0.001) and combined with underlying disease (χ²=7.135, P=0.008). Through further analysis, the changed cases were also characterized as with inadequate auxiliary examination or complex in imaging. Conclusion The online and offline combined MDT diagnosis-treatment mode is feasible. For the patients characterized of elderly (> 69 years old), KPS score ≥80, combined with underlying diseases, with incomplete auxiliary examination or complex in imaging, the offline MDT diagnosis-treatment mode should be adopted or supplemented.

Key words: Neoplasm, Multidisciplinary team, Diagnosis, Therapy

杨光惠, 王茜, 李哲奇, 刘成新, 孙洪福, 李喆, 张海波, 李洪升, 李宝生. 线上和线下联合的癌症多学科综合治疗协作组诊疗模式探讨[J]. 国际肿瘤学杂志, 2020, 47(9): 542-545.

Yang Guanghui, Wang Qian, Li Zheqi, Liu Chengxin, Sun Hongfu, Li Zhe, Zhang Haibo, Li Hongsheng, Li Baosheng. Discussion on online and offline combined multidisciplinary team diagnosis-treatment mode for cancers[J]. Journal of International Oncology, 2020, 47(9): 542-545.

图/表 1

参考文献 10

[1]	Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care[J]. Future Oncol, 2014,10(13):1995-1998. DOI: 10.2217/fon.14.125. doi: 10.2217/FON.14.125 pmid: 25396771
[2]	Taylor C, Shewbridge A, Harris J, et al. Benefits of multidisciplinary team work in the management of breast cancer[J]. Breast Cancer (Dove Med Press), 2013,30(5):79-85. DOI: 10.2147/BCTT.S35581.
[3]	苏向前, 邢加迪. 胃癌多学科综合治疗协作组诊疗模式专家共识[J]. 中国实用外科杂, 2017,37(1):37-38. DOI: 10.19538/j.cjps.issn1005-2208.2017.01.12.
[4]	Selby P, Popescu R, Lawler M, et al. The value and future developments of multidisciplinary team cancer care[J]. Am Soc Clin Oncol Educ Book, 2019,39:332-340. DOI: 10.1200/EDBK_236857. doi: 10.1200/EDBK_236857 pmid: 31099640
[5]	中国医师协会神经外科医师分会脑胶质瘤专业委员会. 胶质瘤多学科诊治(MDT)中国专家共识[J]. 中华神经外科杂志, 2018,34(2):113-118. DOI: 10.3760/cma.j.issn.1001-2346.2018.02.002.
[6]	钱俊, 李德川, 朱远, 等. 大肠癌治疗模式变迁[J]. 中国肿瘤, 2013,22(12):966-969. DOI: 10.11735/j.issn.1004-0242.2013.12.A005.
[7]	Wright FC, De Vito C, Langer B, et al. Multidisciplinary cancer conferences: a systematic review and development of practice standards[J]. Eur J Cancer, 2007,43(6):1002-1010. DOI: 10.1016/j.ejca.2007.01.025. doi: 10.1016/j.ejca.2007.01.025
[8]	European partnership action against cancer consensus group, Borras JM, Albreht T, et al. Policy statement on multidisciplinary cancer care[J]. Eur J Cancer, 2014,50(3):475-480. DOI: 10.1016/j.ejca.2013.11.012. doi: 10.1016/j.ejca.2013.11.012
[9]	吴毓, 蒋旻珏, 贾慧珣, 等. 中国大陆部分医院癌症诊疗模式和临床分期使用情况的调查[J]. 中国癌症杂志, 2015,25(1):67-72. DOI: 10.3969/j.issn.1007-3969.2015.01.012.
[10]	Leidy SD, 陶红兵, 蔡苗, 等. 肿瘤多学科团队实施现状及影响因素研究[J]. 中国医疗管理科学, 2017,7(3):28-33. DOI: 10.3969/j.issn.2095-7432.2017.03.006.

项目	诊疗方案改变(n=23)	诊疗方案未变(n=145)	χ²值	P值
年龄(岁)
≤69	16(69.6)	128(88.3)	4.250	0.039
>69	7(30.4)	17(11.7)
KPS评分
<80	3(13.0)	83(57.2)	15.520	<0.001
≥80	20(87.0)	62(42.8)
是否合并基础疾病
是	15(65.2)	52(35.9)	7.135	0.008
否	8(34.8)	93(64.1)
入院前是否接受抗肿瘤治疗
是	7(30.4)	50(34.5)	0.145	0.703
否	16(69.6)	95(65.5)
肿瘤位置
颈段、胸上段	7(30.4)	23(15.9)
胸中段	8(34.8)	51(35.2)	3.143	0.226
胸下段	8(34.8)	71(49.0)

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	钱晓涛, 石子宜, 胡格, 吴晓维. Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[3]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[4]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[5]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[6]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[7]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[8]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[9]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[10]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[11]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[12]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[13]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[14]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[15]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.

线上和线下联合的癌症多学科综合治疗协作组诊疗模式探讨

Discussion on online and offline combined multidisciplinary team diagnosis-treatment mode for cancers

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 10

相关文章 15

编辑推荐

Metrics

本文评价